-Universitätsklinikder

[98] Manfredi, P. L., Gonzales, G. R., Sady, R., Chandler, S., Payne, R. (2003).
Neuropathic pain in patients with cancer. J Palliat Care 19 (2), 115–118
[99] Mao, J. (2008). Opioid-Induced Hyperalgesia,16 (2), 1–4
[100] Martin, L. A., Hagen, N. A. (1997). Neuropathic pain in cancer patients:
mechanisms, syndromes, and clinical controversies. J Pain Symptom
Manage 14 (2), 99–117
[101] Mattenklodt, P., Ingenhorst, A., Wille, C., Flatau, B., Hafner, C., Geiss, C.,
Sittl, R., Ulrich, K., Griessinger, N. (2008). Multimodale Gruppentherapie
bei Senioren mit chronischen Schmerzen: Konzept und Ergebnisse im Präpost-Vergleich.
Der Schmerz 22 (5), 551–561
[102] Matthews, E. A., Dickenson, A. H. (2001). Effects of spinally delivered N-
and P-type voltage-dependent calcium channel antagonists on dorsal horn
neuronal responses in a rat model of neuropathy. Pain 92 (1-2), 235–246
[103] Max, M. B., Schafer, S. C., Culnane, M., Dubner, R., Gracely, R. H. (1988).
Association of pain relief with drug side effects in postherpetic neuralgia: a
single-dose study of clonidine, codeine, ibuprofen, and placebo. Clin.
Pharmacol. Ther. 43 (4), 363–371
[104] McMillan, S. C. (1996). Pain and pain relief experienced by hospice
patients with cancer. Cancer Nurs 19 (4), 298–307
[105] McQuay, H. J., Tramèr, M., Nye, B. A., Carroll, D., Wiffen, P. J., Moore, R.
A. (1996). A systematic review of antidepressants in neuropathic pain. Pain
68 (2-3), 217–227
[106] Mercadante, S., Arcuri, E., Tirelli, W., Casuccio, A. (2000). Analgesic effect
of intravenous ketamine in cancer patients on morphine therapy: a
randomized, controlled, double-blind, crossover, double-dose study. J Pain
Symptom Manage 20 (4), 246–252
[107] Mercadante, S., Armata, M., Salvaggio, L. (1994). Pain characteristics of
advanced lung cancer patients referred to a palliative care service. Pain 59
(1), 141–145
72